BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/18/2022 12:26:44 PM | Browse: 327 | Download: 681
 |
Received |
|
2021-09-16 20:14 |
|
Peer-Review Started |
|
2021-09-16 20:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-08 03:36 |
|
Revised |
|
2021-11-08 18:05 |
|
Second Decision |
|
2022-02-11 05:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-02-13 17:03 |
|
Articles in Press |
|
2022-02-13 17:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-02-09 16:30 |
|
Typeset the Manuscript |
|
2022-03-09 02:00 |
|
Publish the Manuscript Online |
|
2022-03-18 12:26 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Therapeutic use of melatonin in schizophrenia-more than meets the eye!
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ahmed Naguy |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ahmed Naguy, MBChB, MSc, Staff Physician, Al-Manara CAP Centre, Kuwait Centre for Mental health (KCMH), Jamal Abdul-Nassir Street, Shuwaikh 22094, Kuwait. ahmednagy@hotmail.co.uk |
| Key Words |
Melatonin; Schizophrenia; Chronobiotic; Neuroprotectant; Antipsychotic; Tardive dyskinesia; Metabolic syndrome |
| Core Tip |
Adjuventia Melatonin use in schizophrenia is strongly recommended. This is supported by a modicum of evidence base. Use is multi-folded transcending chronobiotic actions, rectifying sleep disturbance in schizophrenia, to bona fide augmentative antipsychotic actions, mitigating the risk of relentless tardive dyskinesias, curbing the drastic cardio-metabolic syndrome and ultimately neuroprotective actions in the face of neuroprogressive course of schizophrenia over time. |
| Publish Date |
2022-03-18 12:26 |
| Citation |
Naguy A. Therapeutic use of melatonin in schizophrenia-more than meets the eye!. World J Psychiatry 2022; 12(3): 533-535 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i3/533.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i3.533 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
